sarepta therapeutics elevidys - Search News

News

Sarepta Therapeutics, FDA and Elevidys

The Boston Globe · 2d

Sarepta soars after FDA says some patients can get Elevidys

Sarepta Therapeutics Inc. shares rose sharply early Tuesday after US regulators reversed course and recommended that patients who can walk be allowed to take its gene therapy Elevidys again.

Reuters on MSN · 3d

Sarepta resumes shipping of gene therapy Elevidys to patients who can walk

Sarepta Therapeutics said on Monday it will resume shipping of its muscular disorder gene therapy to patients who can walk, sending the company's shares 59% higher in extended trading.

Investopedia on MSN · 3d

Sarepta Therapeutics Stock Surges as FDA Allows Elevidys Sales to Resume

Key Takeaways Sarepta Therapeutics shares jumped in intraday trading Tuesday after the company said it was resuming shipments of one of its drugs.Sales were paused last week as the FDA reviewed a third death of a patient who was taking its muscular dystrophy medication Elevidys.

Fierce Pharma1h

Untangling Sarepta’s gene therapy fallout and a growing trust deficit

Over a whirlwind three weeks, Sarepta Therapeutics has faced tough safety questions around its commercial gene therapy ...

2don MSN

Sarepta shares rebound after shipments of gene therapy Elevidys resume in US

By Bhanvi Satija and Siddhi Mahatole (Reuters) -Sarepta Therapeutics shares snapped a three-day losing streak on Tuesday, as ...

3d

Sarepta Therapeutics Surges Over 40% In Tuesday Pre-Market: What's Going On?

Stock of Sarepta Therapeutics Inc. (NASDAQ: SRPT) surged 38.89% in Tuesday pre-market following the U.S. Food and Drug ...

Stocktwits on MSN2d

Why Did Sarepta Stock Jump 20% On Tuesday? Here’s What JPMorgan, Bernstein, Barclays Said About Elevidys

Shares of Sarepta Therapeutics Inc. (SRPT) traded 20% higher on Tuesday afternoon after the U.S. Food and Drug Administration ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results